Letters to the Editor
COVID-19 cell

Long COVID – Reader Response

Share
By: Emma Smith

In Response to: Keys to understanding long COVID

Dear Editor,

I tested positive on November 4, 2020. Election day in Montana. I spent twelve days virtually bed bound. When my sense of smell came back, I figured I was over the worst.

Three months after, it began to hit in terrifying waves. I was 22. But if I climbed or skied too hard, picked up too many shifts, or didn’t rest, my body would scream at me. When I tried to move, my brain blurred. My limbs felt like wet cement. No matter how much I slept, it wouldn’t go away.

When the wave came, I couldn’t work. I could barely move. Thankfully all my classes were over zoom so I was able to graduate still.

Six doctors over two years said I was depressed. Six months after graduating, my fatigue forced me to stop working at the climbing gym; I moved back home to Oregon. My vitamin B12 was inexplicably low. A month after turning 24, I was reinfected with Covid during my treatment, despite being fully vaccinated.

A month after, I began to develop uncontrollable muscle twitching, weakness, and jerks. My fatigue was worse. Flashing lights and floaters took over my vision. Another month later, my heart would palpitate and drop below 50 beats per minute. My body ached constantly.

An article published by the Washington Post revealed I had Long Covid. After three years of being told by multiple doctors that they didn’t know why a former athlete and journalist could barely make it through the day, I had my answer. However, there is still no cure and no treatment available.

I am a 25-year-old female and considered disabled.

Emma Smith

Are you interested in sharing your input?
Please consider sending an electronic Letter to the Editor to share your opinion on American Nurse Journal content.

What are the guidelines for letter submissions?
Letters should be fewer than 275 words and take as their starting point an article published in American Nurse Journal in the past 2 months. Letters should be exclusive to American Nurse Journal and not submitted to or published in any other media. They must include the writer’s full name. Anonymous letters and letters written under pseudonyms will not be considered. Writers should disclose any personal or financial interest in the subject matter of their letters. Letters should not contain attachments.

Letters are screened prior to approval for posting; not all will be posted. We do not respond to requests for medical or legal advice. No material is intended to be a substitute for professional medical and legal advice.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.


cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

What is the primary purpose of a 3-minute foot assessment in patients with comorbidities such as diabetes or peripheral arterial disease?

Recent Posts